ENTRESTO 49 mg/51 mg, film-coated tablet 56 tablets
Active ingredients: COMPLEXE SODIQUE SACUBITRIL VALSARTAN HÉMIPENTAHYDRATÉ, Sacubitril, Valsartan
Commercialized according to BDPMDispensing in France: Prescription only
Film-coated tablet56 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- ENTRESTO 49 mg/51 mg, comprimé pelliculé
- Pharmaceutical form
- comprimé pelliculé
- Route of administration
- orale
- Presentation description
- 4 plaquette(s) PVC PVDC aluminium de 14 comprimé(s)
- Marketing authorisation holder
- NOVARTIS EUROPHARM (IRLANDE)
- Reimbursement according to BDPM
- 65%
- Reimbursement conditions
- Ce médicament peut être pris en charge ou remboursé par l'Assurance Maladie dans les cas suivants :<br><br>- Insuffisance cardiaque, dans certains cas précisément définis uniquement. ; JOURNAL OFFICIEL ; 11/10/18
- Approval for use in healthcare institutions
- oui
- Commercialization declaration date
- 4 Jan 2016
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
61816438CIP73003791CIP133400930037911Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| VALSARTANcomprimé | 51,4 mg · un comprimé | FT |
| COMPLEXE SODIQUE SACUBITRIL VALSARTAN HÉMIPENTAHYDRATÉcomprimé | — | SA |
| SACUBITRILcomprimé | 48,6 mg · un comprimé | FT |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.
The published catalog does not list other packages of similar medicines.